Methionine
- Generic Name
- Methionine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C5H11NO2S
- CAS Number
- 63-68-3
- Unique Ingredient Identifier
- AE28F7PNPL
- Background
A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals.
- Indication
Used for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.
- Associated Conditions
- Hepatic Encephalopathy (HE)
- Associated Therapies
- Amino acid supplementation
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
- Conditions
- Interventions
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Xiaojun Chen
- Target Recruit Count
- 80
- Registration Number
- NCT05316935
- Locations
- 🇨🇳
Tenth People's Hospital of Tongji University, Shanghai, Shanghai, China
🇨🇳Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
- Conditions
- Interventions
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2020-11-09
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 3
- Registration Number
- NCT03887169
- Locations
- 🇫🇷
Hôpital Necker-Enfants Malades, Paris, Ile De France, France
The Effect of a Liraglutide on IVF in Obese PCOS
- Conditions
- Interventions
- First Posted Date
- 2017-11-27
- Last Posted Date
- 2017-11-27
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 30
- Registration Number
- NCT03353948
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
- Conditions
- Interventions
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Ente Ospedaliero Ospedali Galliera
- Target Recruit Count
- 160
- Registration Number
- NCT03047837
- Locations
- 🇮🇹
Medical Oncology Ente Ospedaliero Ospedali Galliera, Genova, Italy
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
- First Posted Date
- 2016-07-06
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Turku University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02824419
- Locations
- 🇫🇮
Turku University Hospital, Turku, Varsinais-Suomi, Finland
Methionine PET/CT Studies In Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-02-10
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 650
- Registration Number
- NCT00840047
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Treatment of AIDS Vacuolar Myelopathy With Methionine
- Conditions
- First Posted Date
- 2002-03-29
- Last Posted Date
- 2006-05-15
- Target Recruit Count
- 56
- Registration Number
- NCT00032695
- Locations
- 🇺🇸
Beth Israel Medical Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.